XML 36 R24.htm IDEA: XBRL DOCUMENT v3.4.0.3
Acquisitions - Additional Information (Detail) - USD ($)
$ in Millions
Jan. 21, 2016
Dec. 03, 2015
Liberator Medical Holdings, Inc.    
Business Acquisitions and Dispositions [Line Items]    
Percentage of outstanding stock acquired 100.00%  
Business acquisition, purchase consideration cash payment $ 181.1  
Purchase price allocation at fair value, recognition of deferred tax liabilities 31.6  
Business Combination, recognized identifiable assets acquired and liabilities assumed, other net assets and liabilities 11.9  
Purchase price allocation at fair value, goodwill 121.8  
Embo Medical Limited    
Business Acquisitions and Dispositions [Line Items]    
Percentage of outstanding stock acquired   100.00%
Business acquisition, purchase consideration cash payment   $ 21.0
Business Combination, recognized identifiable assets acquired and liabilities assumed, other net assets and liabilities   (2.9)
Purchase price allocation at fair value, goodwill   4.4
Business acquisition, maximum contingent consideration   22.5
Business combination, contingent consideration, liability   16.6
Customer relationships | Liberator Medical Holdings, Inc.    
Business Acquisitions and Dispositions [Line Items]    
Purchase price allocation at fair value, recognition of finite-lived intangible asset $ 53.0  
Customer relationships | Weighted Average | Liberator Medical Holdings, Inc.    
Business Acquisitions and Dispositions [Line Items]    
Estimated useful lives, years 12 years  
Other Intangible Assets | Liberator Medical Holdings, Inc.    
Business Acquisitions and Dispositions [Line Items]    
Purchase price allocation at fair value, recognition of finite-lived intangible asset $ 26.0  
Other Intangible Assets | Weighted Average | Liberator Medical Holdings, Inc.    
Business Acquisitions and Dispositions [Line Items]    
Estimated useful lives, years 8 years  
In-Process Research And Development | Embo Medical Limited    
Business Acquisitions and Dispositions [Line Items]    
Purchase price allocation at fair value, recognition of indefinite-lived intangible asset   $ 36.1
Risk-adjusted discount rate   17.50%